# Menopause symptoms: What's really happening, and what helps?

_By Maurice Lichtenberg · Published 2026-06-14 · Updated 2026-09-29_

The most common menopause symptoms are irregular periods, hot flashes and night sweats (up to 80 in 100 women), sleep problems, mood swings, brain fog, joint pain, more belly fat, vaginal dryness and bladder problems. They usually start in perimenopause, years before the final period, which comes at about 51 on average. In women with frequent hot flashes, those last a median of 7.4 years (SWAN), not a few months. Hormone therapy works best against hot flashes, and there are now two prescription drugs without hormones too. Almost every other symptom has a lever without hormones: resistance training plus protein, CBT-I (a short behavioral therapy for insomnia) for sleep, movement for the joints, and daily sunscreen plus a retinoid for the skin.

Up to 80 in 100 women get hot flashes, on top of weight, brain fog, joints, sleep and skin changes. Most of it has a clear explanation, and for almost all of it there is something you can do.

## On this page

- Am I in menopause? First signs and symptoms
- Hot flashes: What actually helps?
- Why am I gaining weight in menopause, and how do I lose it again?
- Brain fog: Why can I suddenly not concentrate?
- Joint pain in menopause: Is it estrogen, and what helps?
- Sleep problems and night sweats: What actually helps?
- Skin aging and collagen loss: What's happening to my skin?
- What helps across all symptoms?

## Am I in menopause? First signs and symptoms

Menopause is only certain in hindsight: it counts as reached once your period has been gone for 12 months in a row with no other cause. Before that come the transition years, perimenopause, and that is when most symptoms begin. Average age for natural menopause is about 51, shown by the large US cohort study SWAN (Study of Women's Health Across the Nation) [1].

The clinical staging of these transition years is called STRAW+10. If you want to know exactly which stage you are in and how perimenopause and menopause differ, our [perimenopause guide](/en/guide/perimenopause) goes deep [2]. Here we stay with the practical question: which symptoms belong to it, and how do you recognize them?

Here are the symptoms at a glance, and how common they are:

| Symptom | How common | More on this page |
|---|---|---|
| Hot flashes, night sweats | up to 80 in 100 women across the transition [1, 3]; 71.2 percent of German women aged 45 to 60 with complaints [4] | Hot flashes |
| Irregular periods | the typical first sign of perimenopause [2] | This section |
| Sleep problems, night waking | one of the 11 core complaints of the Menopause Rating Scale [6] | Sleep |
| Low mood, irritability, anxiety, exhaustion | a whole domain of the Menopause Rating Scale [6] | FAQ |
| Racing heart, palpitations | the scale's item "heart discomfort" [6] | FAQ |
| Brain fog, forgetfulness | common, usually temporary [11] | Brain fog |
| Joint and muscle pain | more than half of women [13] | Joint pain |
| Belly fat, less muscle | fat gain roughly doubles early in the transition, more of it at the belly [8, 22] | Weight |
| Vaginal dryness, lower libido | the scale's urogenital domain [6] | This section |
| Bladder problems | 42.7 percent of German women with complaints in a survey [4] | This section |
| Thinner, drier skin | collagen drops with years since menopause [17] | Skin |

The most common sign is hot flashes and night sweats, which doctors call vasomotor symptoms (VMS for short). Across the whole transition they hit up to about 80 in 100 women. Depending on the study and definition, the range is roughly 60 to 80 percent [1, 3]. The spread comes down to who was surveyed and whether mild flashes counted.

For German-speaking countries there is a specific number: in a survey of women aged 45 to 60, 81 percent reported some menopausal complaint; among the women with complaints, 71.2 percent reported hot flashes and night sweats and 42.7 percent reported bladder problems [4]. So if it feels like nearly every woman around you is suddenly talking about the same thing, statistically you are right.

A common myth: that hot flashes are a matter of a few months. They are not. In SWAN the median total duration of frequent VMS was 7.4 years. After the final period they persisted for a median of another 4.5 years [5]. So plan in years rather than weeks. That is no reason to panic, but a good reason to take the complaints seriously and not just sit them out if they are wearing you down.

To sort out your complaints there is a well-validated self-assessment tool developed in Germany: the Menopause Rating Scale (MRS). It covers 11 complaints, each scored from 0 (none) to 4 (very severe), grouped into three domains [6, 7]. Here is how it looks:

| Domain | Complaints (MRS items) |
|---|---|
| Somatic (somato-vegetative) | hot flashes and sweating, heart discomfort, sleep problems, joint and muscle complaints |
| Psychological | depressed mood, irritability, anxiety, physical and mental exhaustion |
| Urogenital | sexual problems, bladder problems, vaginal dryness |

The MRS is a self-check for the conversation with your gynecologist, not a diagnostic stamp. Want to score yourself? Our [interactive menopause symptom checker](/en/menopause-test) walks you through the complaints. When several of these complaints come together and your cycle turns irregular, perimenopause is the most likely explanation.

Some symptoms need a doctor soon, not a self-check: any vaginal bleeding once your period has been gone for 12 months, bleeding that gets heavier rather than lighter, and a racing or pounding heart (palpitations) [30]. Most of the time the cause is harmless. But bleeding after menopause can be a sign of cancer, so other causes need ruling out first [30].

In the next sections we go through the most common complaints one by one.

- Menopause only counts in hindsight after 12 months without a period; the average age is about 51 (SWAN) [1].
- Hot flashes and night sweats affect up to 80 percent of women across the transition; depending on the study, 60 to 80 percent [1, 3].
- In Germany, 71.2 percent of women aged 45 to 60 with menopausal complaints reported hot flashes and night sweats (Buhling 2014) [4].
- Frequent VMS last a median of 7.4 years in total and a median of 4.5 years after the final period (SWAN) [5].
- The Menopause Rating Scale (MRS) captures 11 complaints across three domains as a self-check for the doctor's visit [6, 7].
- Any vaginal bleeding after 12 months without a period, heavier bleeding or palpitations belong with a doctor [30].

## Hot flashes: What actually helps?

Hot flashes are the lead symptom, so they get their own answer. Hormone therapy (MHT) works best: in a Cochrane review of 24 randomized trials (3,329 women), oral hormone therapy cut how often hot flashes came by about 75 percent compared with placebo [25]. Whether it fits you depends on your age, how long ago your last period was and your personal risks. The [HRT guide](/en/guide/hormonersatztherapie-hrt-trt) walks you through that.

If hormones are not an option, there are now two prescription drugs without hormones. Both work in the brain's temperature control center. There they block receptors for a messenger called neurokinin, which helps set off the heat surge.

- **Fezolinetant (Veoza)** has been approved in the EU since December 2023. In the SKYLIGHT 1 trial it reduced moderate to severe hot flashes clearly more than placebo [26]. One safety point: in rare cases it can damage the liver. So since January 2025 the EU label requires a liver blood test before you start and every month for the first three months [23].
- **Elinzanetant (Lynkuet)** was approved in the EU in November 2025 and has been in German pharmacies since April 2026. You take it once a day at bedtime. In the OASIS 1 and 2 trials it reduced hot flashes and improved sleep compared with placebo [27].

Without a prescription: a cool bedroom, layers you can peel off and less alcohol in the evening make flashes easier to live with. They do not switch them off. If hot flashes wreck your sleep or your days, that is reason enough to talk to your gynecologist about the options above.

- Hormone therapy cut hot flash frequency by about 75 percent versus placebo in a Cochrane review [25].
- Two non-hormonal prescription drugs exist: fezolinetant (Veoza, EU since December 2023) and elinzanetant (Lynkuet, in German pharmacies since April 2026) [26, 27].
- Veoza needs a liver blood test before you start and monthly for the first three months [23].
- A cool bedroom, layered clothing and less alcohol make flashes easier to bear, but do not stop them.

## Why am I gaining weight in menopause, and how do I lose it again?

First the most important clarification: menopause does not make the number on the scale jump up by itself. What shifts is fat distribution. Weight rises slowly with aging anyway, but around the transition more fat is laid down at the belly and around the organs (visceral fat), and muscle mass declines [8, 22].

The SWAN data show this cleanly. At the start of the transition the rate at which fat mass is gained roughly doubles, while lean mass (mostly muscle) drops, until about two years after the final period [8]. But weight gain itself shows no separate menopause spike: it tracks with chronological age. So menopause redistributes the fat. It does not by itself drive the number up [8].

This matters for one reason: visceral fat, the fat around the organs, is more metabolically active and more harmful than the fat directly under the skin. It is linked to insulin resistance and cardiovascular risk. So the fact that your waist changes while the scale barely moves is neither imagined nor a purely cosmetic issue.

The most effective lever is known, and it is in your hands: resistance training plus enough protein to hold on to muscle. The international PROT-AGE consensus paper recommends 1.0 to 1.2 grams of protein per kilogram of body weight a day for older adults, combined with resistance exercise. That is clearly more than the old 0.8 grams. If you train actively, aim for 1.2 grams per kilogram or more [9]. For a woman weighing 70 kilograms, that is about 70 to 84 grams of protein a day. Spread it across meals: roughly a palm-sized portion per meal from quark, eggs, legumes, fish or poultry.

Keeping muscle keeps your resting metabolism up and works against the shift toward belly fat. The reason is simple: muscle tissue burns energy even at rest, and it is exactly this lean mass that is lost during the transition if you do nothing about it. Resistance training here is not an optional extra for sporty women but the most direct counter to what the body does on its own during the transition.

Does hormone therapy help you lose weight? The internet often says yes. It does not. A Cochrane review (28 randomized trials, 28,559 women) found no evidence that estrogen or combined hormone therapy changes body weight or prevents menopausal weight gain [10]. Menopausal hormone therapy (MHT, the medical umbrella term for HRT) is not a weight-loss drug, and doctors do not prescribe it for that. Whether it moves fat away from the belly is open: the Cochrane authors found too little data on waist-hip ratio or fat mass to say [10]. If you are weighing whether MHT makes sense for your symptoms overall, you will find the full benefit-risk discussion in our [HRT guide](/en/guide/hormonersatztherapie-hrt-trt).

In practice this means: resistance training two to three times a week, a solid protein source at every meal, and patience with the scale. You are working against the shift in body composition, not against a fixed hormone number.

- Menopause shifts fat toward the belly and organs (visceral) [22], rather than driving the scale up on its own [8].
- At the start of the transition the rate of fat gain roughly doubles and muscle mass declines (SWAN) [8].
- PROT-AGE recommends 1.0 to 1.2 g of protein per kg of body weight a day plus resistance training to keep muscle [9].
- A Cochrane review (28 trials) found no evidence that hormone therapy changes body weight [10].
- MHT is not a weight-loss drug; the Cochrane review found too little data to judge its effect on fat distribution [10].

## Brain fog: Why can I suddenly not concentrate?

If you have started concentrating worse lately, searching for words, or feeling more forgetful: this is common, it belongs to the transition, and it is usually temporary. That is exactly what SWAN shows. In a 4-year analysis of 2,362 women, processing speed (how fast you take in and handle information) and verbal memory stopped improving with practice during perimenopause. Normally scores creep up a little each time you repeat a test, because you learn it. In perimenopause that gain was missing, but scores did not actually drop. After menopause, the learning effect came back [11].

Here is the point to take away: brain fog in menopause is not early-onset dementia. It is a dip during the transition that usually rebounds afterward. That framing takes away much of the fear the symptom tends to trigger.

Bad nights and night sweats make any day harder, and treating them is worth it on their own terms. But SWAN tested the link directly: over 6 years in 1,903 women, hot flashes and poor sleep did not explain the dip in test scores. Low mood and anxiety had small effects [21]. So treat sleep and hot flashes because they wear you down, not because they are proven to cause the fog.

Brain fog is a passing learning dip, not a brain injury. How to tackle sleep specifically is below and in the [sleep guide](/en/guide/sleep). What else helps: regular movement, doing tasks one after another rather than in parallel, and not relying on memory alone for important things but using notes and lists while the transition lasts.

Does hormone therapy help the head? The evidence is mixed, and brain protection is not proven. The WHI Memory Study (WHIMS) followed women aged 65 and over who started estrogen plus progestin. Their risk of probable dementia roughly doubled:

- 45 versus 22 cases per 10,000 person-years (one person-year = one woman followed for one year)
- hazard ratio 2.05 (95 percent confidence interval 1.21 to 3.48; P=0.01) [12]

That is a late start, far past menopause, and it shows harm rather than protection. It does not prove a cognitive benefit of an early MHT start either. Timing and who it suits are covered in the [HRT guide](/en/guide/hormonersatztherapie-hrt-trt).

Bottom line: take brain fog seriously, but do not catastrophize it. Repair sleep, treat hot flashes, keep moving, and in most cases the head clears again after the transition.

- In SWAN (2,362 women), speed and verbal memory stopped improving with practice in perimenopause and recovered afterward [11].
- Brain fog is usually temporary and not a sign of early dementia [11].
- Hot flashes and poor sleep did not explain the dip in SWAN; low mood and anxiety had small effects [21].
- The WHI Memory Study found a doubled dementia risk in women 65 and over on estrogen plus progestin (HR 2.05) [12].
- Brain protection from hormone therapy is not proven; the evidence is mixed [12].

## Joint pain in menopause: Is it estrogen, and what helps?

Yes, estrogen probably plays a role. Joint pain (arthralgia) affects more than half of women around menopause, and it appears to become more common with the transition. The leading explanation is the drop in estrogen, which normally has a hand in pain processing, immune cells and cartilage cells [13]. When that protection falls away, knees, fingers and shoulders make themselves heard.

One caveat: so-called menopausal arthralgia is real, but partly a diagnosis of exclusion. A review titled *Menopausal arthralgia: fact or fiction* concludes that the link is real but understudied. There is no dedicated treatment for it [13]. So before you blame everything on hormones, rule out other causes with your doctor: osteoarthritis (joint wear), inflammatory arthritis such as rheumatoid arthritis (which can newly appear at this age), thyroid disease, and vitamin D deficiency [13]. That belongs in a medical conversation, not in self-diagnosis.

A randomized trial shows that estrogen really does act on the joints. It used the estrogen-only arm of the Women's Health Initiative: 10,739 women without a uterus, on conjugated estrogen 0.625 mg a day or placebo. After one year, joint pain was less common on estrogen than on placebo (76.3 versus 79.2 percent, P=0.001). The effect held through year three [14]. Swollen joints, though, were slightly more common on estrogen (42.1 versus 39.7 percent, P=0.02), so the picture is not uniformly clear [14]. All of this is real but small, a gap of a few percentage points. Read it as a pointer to the mechanism, not a treatment recommendation. Whether hormone therapy makes sense for you is covered in the [HRT guide](/en/guide/hormonersatztherapie-hrt-trt).

A practical note for context: menopausal joint pain often affects several joints at once and is often stiffest in the morning and after rest. That very pattern overlaps with inflammatory arthritis, which is why a medical work-up matters so much. Persistent swelling, redness or warmth over a joint, or morning stiffness lasting well over half an hour, should be checked out rather than chalked up to hormones.

What you can do yourself is well supported and comes first: movement. A combination of resistance training and mobility or endurance keeps joints supple and the muscles that support the joint strong. On top of that, keep an eye on weight and have the contributing causes named above treated. Here, exercise is not a consolation prize but the first line [13].

- Joint pain affects more than half of women around menopause; the estrogen drop is the leading explanation [13].
- Menopausal arthralgia is partly a diagnosis of exclusion: rule out osteoarthritis, arthritis, thyroid and vitamin D first [13].
- In the estrogen arm of the WHI, joint pain occurred less often after one year (76.3 versus 79.2 percent, P=0.001) [14].
- The estrogen effect on joints is real but small, and not a standalone treatment recommendation [14].
- First line is movement: resistance training plus mobility or endurance, alongside weight management [13].

## Sleep problems and night sweats: What actually helps?

The best-supported first step against menopausal insomnia is not a pill. It is a short, targeted therapy: cognitive behavioral therapy for insomnia (CBT-I), which the European insomnia guideline names as first-line treatment for adults [24]. Sleep problems are one of the 11 core complaints on the Menopause Rating Scale. They are closely tied to night sweats and to trouble falling or staying asleep (insomnia) [6]. Many women wake from a heat surge. Others simply lie awake for no obvious reason.

CBT-I teaches you to reset your sleep pressure (the drive to sleep that builds while you are awake) and your sleep-wake rhythm, rather than just numbing the symptoms. A MsFLASH trial tested it in 106 peri- and postmenopausal women with hot flashes. CBT-I by telephone was compared with menopause education alone. It brought clear, clinically meaningful and lasting gains in sleep quality and insomnia severity. It also reduced how much the hot flashes got in the way of daily life [15].

The key point: CBT-I works on the insomnia itself, even when the hot flashes are still there [15]. So you do not have to wait for the VMS to go away, and you do not necessarily need a sleeping pill either. That matters especially in menopause, because many women assume that without treating the hot flashes nothing can be done about sleep anyway. The evidence says the opposite.

Sleep hygiene helps on top, but it does not replace CBT-I. That means fixed times, a cool dark bedroom, a screen break in the evening, and less caffeine and alcohol from late afternoon on. For night sweats, a cool bedroom, breathable bedding and light sleepwear that absorbs sweat all help in practice. None of that fixes the cause. It makes the nights more bearable while you work on the insomnia itself.

If hot flashes are what keeps waking you, treat them too. For moderate to severe hot flashes there are now two non-hormonal prescription drugs: fezolinetant (Veoza, EU since December 2023) and elinzanetant (Lynkuet, EU since November 2025, in German pharmacies since April 2026). Veoza needs liver blood tests before and during the first months of treatment [23]. In the OASIS trials, elinzanetant also improved sleep [27]. More on both in the hot flash section above.

In Germany, CBT-I is within reach, not a luxury. Behavioral therapy is in principle covered by statutory health insurance as guideline psychotherapy (Richtlinienpsychotherapie, the talk therapies public insurers pay for), and for insomnia there are additional digital programs, some as an app on prescription (DiGA) covered by insurance (as of 2026, when in doubt clarify with your doctor or insurer). Waiting times for a therapy slot do vary, though.

How sleep architecture works and how to improve deep sleep on purpose is covered in our [sleep guide](/en/guide/sleep). For menopause the rule is: take the insomnia seriously as its own problem, start with CBT-I, and treat the night sweats in parallel.

- Sleep problems are one of the 11 core MRS symptoms and closely tied to night sweats and insomnia [6].
- CBT-I (behavioral therapy for insomnia) is the guideline first line against insomnia, and it works in menopause [15, 24].
- In a MsFLASH trial (106 women), telephone CBT-I produced clear, lasting sleep improvements [15].
- CBT-I works on the insomnia itself, even when the hot flashes persist [15].
- In Germany, CBT-I is accessible as guideline psychotherapy and partly as an app on prescription (DiGA).

## Skin aging and collagen loss: What's happening to my skin?

If your skin seems to get thinner, drier and more wrinkled faster after menopause, you are not imagining it. The often-cited number: women lose roughly 30 percent of their skin collagen in the first 5 years or so after menopause, then about 1 to 2 percent a year [16]. Treat the 30 percent as a rule of thumb. It is the widely quoted summary of Brincat's work from the 1980s, not a figure measured in any one paper. The original paper reports a decline of 1 to 2 percent per year [16, 17].

That estrogen deficiency is behind the collagen loss is backed by data. Brincat and colleagues showed that skin collagen and skin thickness decline with years since menopause, not with chronological age alone [17]. A study by Affinito and colleagues found a clear drop in skin collagen types I and III in women after menopause compared with women before it (P<0.01), what the authors called an estrogen-related phenomenon [18]. And in a small study with estradiol gel (16 women, 12 months), the collagen content of abdominal skin rose significantly (P<0.001) [19]. That explains the mechanism, but it is not a skincare prescription: estrogen on or for the skin is off-label, meaning not approved for that purpose, and not a standard recommendation.

What you can actually do is, fortunately, well supported and available without hormones. The best evidence among creams belongs to retinoids (vitamin A acid, tretinoin). A systematic review of 7 randomized trials found that tretinoin reliably improves fine lines, uneven pigmentation, sallowness and age spots, with first effects from about one month and benefit out to 24 months, because it stimulates new collagen and inhibits collagen-degrading enzymes [20]. In Germany tretinoin is prescription-only and not reimbursed for pure anti-aging use (self-pay); over-the-counter retinol cosmetics work more weakly.

The highest-yield lever, though, is simple and cheap: UV protection. Photoaging from UV radiation is a larger and more controllable driver of visible skin aging than the hormonal share, which is why daily broad-spectrum sun protection is the non-negotiable baseline. The hormonal share of skin aging is real, but you can only nudge it. The UV share is large and entirely in your hands. So if you want to do something for your skin in menopause, you start not with hormones but with sunscreen and a retinoid. The full skin protocol with retinoids, sunscreen and actives is in the [skin-aging guide](/en/guide/hautalterung-stoppen).

- The established rule of thumb: about 30 percent skin collagen lost in the first 5 years, then 1 to 2 percent a year (Brincat) [16, 17].
- Skin collagen and thickness decline with years since menopause, not with chronological age alone [17].
- After menopause, skin collagen types I and III drop clearly, an estrogen-related phenomenon [18].
- Topical retinoids (tretinoin) improved wrinkles, pigment and sallowness in 7 randomized trials, with effects from about one month [20].
- Estrogen for the skin is off-label; the proven basics are retinoids and, above all, daily UV protection [19, 20].

## What helps across all symptoms?

For every area there is a lever without hormones: resistance training and protein for body composition, CBT-I for sleep, movement for the joints, retinoids and sunscreen for the skin. For hot flashes there are now two non-hormonal prescription drugs as well.

And there is hormone therapy, which works most strongly against hot flashes [25]. Whether MHT is right for you depends on the pros and cons, the reinterpretation of the WHI study and the timing window (before 60 and within 10 years of menopause). Settle it with the detailed discussion in the [HRT guide](/en/guide/hormonersatztherapie-hrt-trt) and with your gynecologist.

- Nearly every symptom has a lever without hormones: strength and protein, CBT-I, movement, sunscreen plus retinoid.
- Hormone therapy is the most effective treatment for hot flashes [25].
- Whether MHT fits you depends on your risks and timing; the HRT guide and your gynecologist help you decide.


## FAQ

### When does menopause start, and what are the first signs?

Menopause itself only counts in hindsight, once the period has been gone for 12 months in a row; the average age is about 51 (SWAN) [1]. But symptoms usually begin years earlier, in perimenopause. Often your cycle changes first: periods come closer together or further apart [2], and they can get heavier or lighter. Around the same time many women notice hot flashes, night sweats, poorer sleep and mood swings. The Menopause Rating Scale, with its 11 complaints, helps you sort them [6].

### Can menopause start at 40?

Perimenopause symptoms can start in your 40s, while menopause itself comes at about 51 on average [1]. If your periods stop before 40, doctors call it premature ovarian insufficiency (POI). Between 40 and 45 it counts as early menopause. Both belong with a gynecologist, because missing estrogen affects bones and heart. With POI, hormone replacement is usually advised at least until the typical age of menopause [29].

### How long do hot flashes in menopause last?

Longer than most people think. In SWAN the median total duration of frequent hot flashes and night sweats was 7.4 years. After the final period they persisted for a median of another 4.5 years [5]. The idea that it is over after a few months does not hold for most women.

### What helps best against hot flashes?

Hormone therapy works best: in a Cochrane review of 24 trials it cut how often hot flashes came by about 75 percent compared with placebo [25]. Without hormones there are two prescription drugs, fezolinetant (Veoza) and elinzanetant (Lynkuet, in German pharmacies since April 2026). Both reduced hot flashes clearly more than placebo in large trials [26, 27]. Veoza needs liver blood tests before and during the first months of treatment [23]. A cool bedroom and layered clothing help too.

### How can I tell I am in menopause while on the pill?

It is harder than without it. The combined pill causes regular withdrawal bleeds, and its estrogen can dampen hot flashes, so the two clearest signs are hidden. Watch for other changes, like poorer sleep, mood swings or vaginal dryness. A hormone blood test (FSH) is not a reliable way to identify menopause while you take combined hormonal contraception [28]. The combined pill is generally not recommended from age 50 [31], so ask your gynecologist when and how to stop or switch.

### Is a racing heart normal in menopause?

Heart discomfort, like palpitations or a racing heart, is one of the 11 complaints on the Menopause Rating Scale [6], and it often comes together with a hot flash. It is common, but not something to shrug off on your own. The NHS advises seeing a doctor for palpitations [30], who can check things like an ECG and thyroid values. If you also have chest pain, shortness of breath or feel faint, get help right away.

### Can menopause affect your mood and mental health?

Yes. Low mood, irritability, anxiety and exhaustion make up one of the three domains of the Menopause Rating Scale [6]. The risk of depressive symptoms rises during the transition [1]. Poor sleep from night sweats adds to it. If low mood hangs on for weeks or you lose interest in things you used to enjoy, talk to your doctor. That is treatable, not something to sit out.

### Do you inevitably gain weight in menopause?

No, menopause does not drive the number on the scale up on its own [8]. What shifts is fat distribution: more fat at the belly and around the organs [22], less muscle mass [8]. The most effective counter-lever is resistance training plus enough protein; the PROT-AGE paper recommends 1.0 to 1.2 g per kg of body weight a day [9].

### Does hormone therapy help with weight loss in menopause?

No. A Cochrane review (28 trials) found no evidence that estrogen or combined hormone therapy changes body weight or prevents weight gain [10]. MHT is not a weight-loss drug and is not prescribed for that. The full benefit-risk discussion is in the [HRT guide](/en/guide/hormonersatztherapie-hrt-trt).

### Is brain fog in menopause a sign of dementia?

As a rule, no. In SWAN, speed and verbal memory stopped improving with practice during perimenopause and recovered afterward [11]. Hot flashes and poor sleep did not explain that dip, but treating them still makes daily life easier [21].

### What helps most against sleep problems in menopause?

The guideline first line is cognitive behavioral therapy for insomnia (CBT-I) [24]. In a MsFLASH trial of 106 women it produced clear, lasting improvements in sleep and insomnia versus plain education, and it works even when the hot flashes persist [15]. In Germany it is accessible as guideline psychotherapy and partly as an app on prescription (DiGA).

### Does joint pain in menopause really come from estrogen?

Probably in part. More than half of women around menopause have joint pain, and the estrogen drop is the leading explanation [13]. In the estrogen arm of the WHI, joint pain occurred less often after one year (76.3 versus 79.2 percent) [14]. Important: osteoarthritis, arthritis, thyroid disease and vitamin D deficiency should be ruled out medically first [13].

### What helps against skin aging in menopause?

The highest-yield lever is daily broad-spectrum sun protection, because UV radiation is the larger and more controllable driver of visible skin aging. Among creams, retinoids (tretinoin) have the best evidence: 7 randomized trials showed better wrinkles, pigmentation and sallowness from about one month [20]. Estrogen for the skin, by contrast, is off-label and not a standard recommendation [19]. More in the [skin-aging guide](/en/guide/hautalterung-stoppen).

## Sources

- El Khoudary SR, Greendale G, Crawford SL, Avis NE, Brooks MM, Thurston RC, Karvonen-Gutierrez C, Waetjen LE, Matthews K. (2019). The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN). Menopause. https://doi.org/10.1097/GME.0000000000001424
- Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ. (2012). Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopause. https://doi.org/10.1097/gme.0b013e31824d8f40
- Thurston RC, Joffe H. (2011). Vasomotor symptoms and menopause: findings from the Study of Women's Health Across the Nation. Obstetrics and Gynecology Clinics of North America. https://doi.org/10.1016/j.ogc.2011.05.006
- Buhling KJ, Daniels BV, Studnitz FSGV, Eulenburg C, Mueck AO. (2014). The use of complementary and alternative medicine by women transitioning through menopause in Germany: results of a survey of women aged 45-60 years. Complementary Therapies in Medicine. https://doi.org/10.1016/j.ctim.2013.12.004
- Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC. (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2014.8063
- Heinemann K, Ruebig A, Potthoff P, Schneider HPG, Strelow F, Heinemann LAJ, Do MT. (2004). The Menopause Rating Scale (MRS) scale: a methodological review. Health and Quality of Life Outcomes. https://doi.org/10.1186/1477-7525-2-45
- Heinemann LAJ, DoMinh T, Strelow F, Gerbsch S, Schnitker J, Schneider HPG. (2004). The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health and Quality of Life Outcomes. https://doi.org/10.1186/1477-7525-2-67
- Greendale GA, Sternfeld B, Huang MH, Han W, Karvonen-Gutierrez C, Ruppert K, Cauley JA, Finkelstein JS, Jiang SF, Karlamangla AS. (2019). Changes in body composition and weight during the menopause transition. JCI Insight. https://doi.org/10.1172/jci.insight.124865
- Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, Phillips S, Sieber C, Stehle P, Teta D, Visvanathan R, Volpi E, Boirie Y. (2013). Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2013.05.021
- Kongnyuy EJ, Norman RJ, Flight IHK, Rees MC. (2000). Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD001018
- Greendale GA, Huang MH, Wight RG, Seeman T, Luetters C, Avis NE, Johnston J, Karlamangla AS. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology. https://doi.org/10.1212/WNL.0b013e3181a71193
- Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study (WHIMS). JAMA. https://doi.org/10.1001/jama.289.20.2651
- Magliano M. (2010). Menopausal arthralgia: fact or fiction. Maturitas. https://doi.org/10.1016/j.maturitas.2010.04.009
- Chlebowski RT, Cirillo DJ, Eaton CB, Stefanick ML, Pettinger M, Carbone LD, Johnson KC, Simon MS, Woods NF, Wactawski-Wende J. (2013). Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial. Menopause. https://doi.org/10.1097/GME.0b013e31828392c4
- McCurry SM, Guthrie KA, Morin CM, Woods NF, Landis CA, Ensrud KE, Larson JC, Joffe H, Cohen LS, Hunt JR, Newton KM, Otte JL, Reed SD, Sternfeld B, Tinker LF, LaCroix AZ. (2016). Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2016.1795
- Brincat M, Kabalan S, Studd JW, Moniz CF, de Trafford J, Montgomery J. (1987). A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman. Obstetrics and Gynecology
- Brincat M, Moniz CF, Studd JWW, Darby A, Magos A, Emburey G, Versi E. (1985). Long-term effects of the menopause and sex hormones on skin thickness. British Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/j.1471-0528.1985.tb01091.x
- Affinito P, Palomba S, Sorrentino C, Di Carlo C, Bifulco G, Arienzo MP, Nappi C. (1999). Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas. https://doi.org/10.1016/S0378-5122(99)00077-8
- Brincat M, Versi E, O'Dowd T, Moniz CF, Magos A, Kabalan S, Studd JWW. (1987). Skin collagen changes in post-menopausal women receiving oestradiol gel. Maturitas. https://doi.org/10.1016/0378-5122(87)90045-4
- Sitohang IBS, Makes WI, Sandora N, Suryanegara J. (2022). Topical tretinoin for treating photoaging: a systematic review of randomized controlled trials. International Journal of Women's Dermatology. https://doi.org/10.1097/JW9.0000000000000003
- Greendale GA, Wight RG, Huang MH, Avis N, Gold EB, Joffe H, Seeman T, Vuge M, Karlamangla AS. (2010). Menopause-associated symptoms and cognitive performance: results from the Study of Women's Health Across the Nation. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwq067
- Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. (2008). Increased visceral fat and decreased energy expenditure during the menopausal transition. International Journal of Obesity. https://doi.org/10.1038/ijo.2008.25
- European Medicines Agency; Astellas Pharma. (2025). Veoza (fezolinetant): risk of drug-induced liver injury and new recommendations on monitoring of liver function before and during treatment (DHPC). https://www.ema.europa.eu/en/medicines/dhpc/veoza
- Riemann D, Espie CA, Altena E, Arnardottir ES, Baglioni C, Bassetti CLA, Bastien C, Berzina N, Bjorvatn B, Dikeos D, et al. (2023). The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. Journal of Sleep Research. https://doi.org/10.1111/jsr.14035
- MacLennan AH, Broadbent JL, Lester S, Moore V. (2004). Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD002978.pub2
- Lederman S, Ottery FD, Cano A, Santoro N, Shapiro M, Stute P, Thurston RC, English M, Franklin C, Lee M, Neal-Perry G. (2023). Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. https://doi.org/10.1016/S0140-6736(23)00085-5
- Pinkerton JV, Simon JA, Joffe H, Maki PM, Nappi RE, Panay N, Soares CN, Thurston RC, Caetano C, Haberland C, Haseli Mashhadi N, Krahn U, Mellinger U, Parke S, Seitz C, Zuurman L. (2024). Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials. JAMA. https://doi.org/10.1001/jama.2024.14618
- National Institute for Health and Care Excellence (NICE). (2015). Menopause: identification and management (NG23). https://www.nice.org.uk/guidance/ng23
- ESHRE Guideline Group on POI; Webber L, Davies M, Anderson R, et al. (2016). ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproduction. https://doi.org/10.1093/humrep/dew027
- NHS. (2026). Symptoms of menopause and perimenopause. https://www.nhs.uk/conditions/menopause-and-perimenopause/symptoms/
- Faculty of Sexual & Reproductive Healthcare (FSRH). (2017). Contraception for Women Aged Over 40 Years (August 2017, amended May 2025). https://www.fsrh.org/standards-and-guidance/documents/fsrhguidance-contraception-for-women-aged-over-40-years-2017/

_Full guide: https://longevity-germany.com/en/guide/wechseljahre-symptome_

---

_Canonical: https://longevity-germany.com/en/guide/wechseljahre-symptome · Part of Longevity Cities · Updated 2026-09-29_